Trademarkia Logo

Canada

C$
GEOMETRIC SHAPES DESIGN
FORMALIZED

on 8 May 2024

Last Applicant/ Owned by

Boehringer Ingelheim International GmbH

Binger Strasse 17355218 Ingelheim

DE

Serial Number

2326201 filed on 3rd Apr 2024

GEOMETRIC SHAPES DESIGN

Trademark usage description

pharmaceutical preparations for the prevention and treatment of diseases and disorders of the alimentary tract and metabolism, namely, renal diseases, Read More

Vienna Information


26 . 4 . 1

SquaresCarrés

26 . 4 . 4

Other irregular parallelograms, trapezia and quadrilaterals, quadrilaterals containing one or more rounded cornersAutres parallélogrammes, trapèzes et quadrilatères irréguliers, quadrilatères avec un ou plusieurs coins arrondis

26 . 4 . 7

Two quadrilaterals, one inside the otherDeux quadrilatères, l'un dans l'autre

26 . 4 . 10

Quadrilaterals containing one or more circles, ellipses or polygonsQuadrilatères contenant un ou plusieurs cercles, ellipses ou polygones

26 . 4 . 24

Quadrilaterals with dark surfaces or parts of surfacesQuadrilatères avec surface ou partie de la surface foncée

26 . 4 . 26

Quadrilaterals with cutout areasQuadrilatères avec des zones découpées

26 . 1 . 1

CirclesCercles

26 . 1 . 4

Two circles, two ellipses, one inside the otherDeux cercles, deux ellipses, l'un dans l'autre

26 . 1 . 24

Circles or ellipses with dark surfaces or parts of surfacesCercles ou ellipses avec surface ou partie de la surface foncée

26 . 1 . 26

Circles or ellipses with cutout areasCercles ou ellipses avec des zones découpées

29 . 1 . 4

BlueBleu

29 . 1 . 5

VioletViolet

Classification Information


Class [005]
Pharmaceutical preparations for the prevention and treatment of diseases and disorders of the alimentary tract and metabolism, namely, renal diseases, liver diseases, pancreas diseases, digestive system disorders, gastrointestinal diseases and disorders, obesity; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the blood and blood forming organs, namely, vascular diseases, hematology, blood disorders; pharmaceutical preparations for the prevention and treatment of cardiovascular diseases and disorders, musculoskeletal diseases and disorders, central nervous system diseases and disorders, peripheral nervous system diseases and disorders; pharmaceutical preparations for the prevention and treatment of genitourinary diseases, urological diseases, infertility, sexually transmitted diseases, inflammatory pelvic diseases; pharmaceutical preparations for the prevention and treatment of respiratory diseases; pharmaceutical preparations for the prevention and treatment of dermatological diseases and disorders, damaged skin and tissues, namely, rashes, sores, psoriasis, eczema; pharmaceutical preparations for the prevention and treatment of inflammation and inflammatory diseases and disorders, namely, anti-inflammatories; pharmaceutical preparations for the prevention and treatment of ophthalmological diseases and disorders; pharmaceutical preparations for the treatment and prevention of hormonal diseases and disorders; pharmaceutical preparations for the treatment and prevention of infectious diseases and disorders and viral infections, namely, antibiotics, anti-infectives, antivirals; pharmaceutical preparations for the prevention and treatment of oncological diseases; pharmaceutical preparations for the prevention and treatment of auto-immune diseases and disorders; pharmaceutical preparations, namely, cell based immune therapeutics for treatment of cancer; pharmaceutical preparations, namely, cell based immune therapeutics for treatment of immunological diseases, namely, autoimmune diseases and disorders; pharmaceutical preparations, namely, cell based immune therapeutics for treatment of infectious diseases, namely viral infections.


Classification kind code

12

Mark Details


Serial Number

2326201

Mark Type

Trademark

Legal History


Action TakenStatus
Submitted for opposition 257
on 9th May 2024
Designation Notification - Madrid Protocol
Submitted for opposition 1
on 8th May 2024
Created
Submitted for opposition 31
on 8th May 2024
Formalized
Submitted for opposition 228
on 3rd Apr 2024
International Registration
Submitted for opposition 30
on 3rd Apr 2024
Filed